Partnerships & Alliances| Remediumone

At present, we work with a local network of 46 trial sites spread across the country – tertiary care hospitals, primary healthcare facilities and university departments – in collaboration with more than 300 medical specialists. This makes the CTU – RemediumOne the largest collaborative clinical research centre in the country.

We have also established strong international collaborations with numerous universities and internationally recognized centres of excellence. These include:

The George Institute for Global Health
Clinical Trial Service Unit, University of Oxford
Clinical Trials Unit, Imperial College
Duke Clinical Research Institute
Stroke Centre, University of Nottingham
Duke-NUS Graduate Medical School
Public Health Research Institute, McMaster University
All India Institute of Medical Sciences
University of Notre Dame
Bill & Melinda Gates Foundation
Unitaid

We have also provided clinical trial expertise to research-based biotechnology industry with other academic institutions through global clinical trial networks to develop new therapies. These have been in diverse therapeutic areas including diabetes, high blood pressure, cardiovascular disease, stroke, breast cancer, rare diseases in nephrology as well as development of a tetravalent vaccine against dengue. Our expertise has contributed to protocol design and successful conduct of studies based on complex protocols. As a result, we are now recognized as a regional centre of excellence for clinical research and work closely with the global alliance for chronic disease.

Furthermore, the Postgraduate Institute of Medicine (PGIM), University of Colombo has recognized research centres managed by the CTU – RemediumOne collaboration for hands-on training in clinical trials. At present, postgraduate students following programmes in Clinical Pharmacology are now placed in our study centres under the aegis of the CTU for training in clinical trial methodology. Academic staff in the Department of Pharmacology who provide scientific support to the work of the CTU have been included into steering committees of major global studies in recognition of their domain expertise.

CRA

“I really got good support from your end in conducting visit, updating EDC and timely resolving the queries and yes during my on site and telephonic monitoring visits all these days and thanks for this.”

Sachin S Mangalvedhekar

Senior Manager-Clinical Project Management ; SiroClinPharm

“I fall short of words, I cannot emphasize how much I enjoyed working with you, my experience of this association of 2.5+ years !! R1 has planted a seed of clinical research in Sri Lanka few years back, you all have watered it, its growing rapidly and would soon be a gigantic tree in the near future.”

Sanofi

Senior Project Manager

“Yesterday the Sri Lankan team has randomized their 200th Patient…….CONGRATULATIONS to the entire team. All possible because of your persistent hard work, and dedication of the site team to achieve this.”

Karen McCarthy

Sr.Director – Project Management; Infectious diseases

“I am delighted with the DEN-301 study progress, as you are aware, it’s a busy time with second vaccinations and surveillance but I am very pleased with the progress reports I receive from the team in relation to Sri Lanka.”

Branka Duvnjak

Head of site management, Ergomed

“I am finally back home; i.e. in the office, after the meeting in Hamburg – Germany where I went directly from Colombo. I am still under a big impression of all I saw and experienced in Sri Lanka and I am looking forward to work together with all of you – RO colleagues on this and other studies in the future. I am sure that together we can achieve a lot of success.”

Anirban Roy Chowdhury

Senior Director, Global Clinical Trial Operations at MSD Pharmaceuticals

“This is a historical day for all of us. Thanks for all your guidance and support in making this happen. I know this is possible through a wonderful team work. Please convey my heartfelt thanks to all. I look forward to your continued support as we move ahead in this journey.”

Dr. Yanee and Debbie

Medical MonitorsTakeda Pharmaceuticals

“Sri Lanka has hit their country target of 2,100 subjects last Saturday. On behalf of Takeda Vaccines, we would like to congratulate you and your team for reaching your target this early. This is a big achievement, your country is the second globally to reach their target. Thank you very much for all the efforts put into this !”

Mubarak Naqvi

Senior Director, Medical & Regulatory Affairs, Sanofi

“Congratulations to this amazing team for their OUTSTANDING performance !! Your hard work and persistence is greatly appreciated. Above all, your patient centric approach and commitment to quality and ethics is exemplary. I wish you all the very best. Keep up the good work.”

Prof. Anushka Patel

Chief Scientist, The George Institute for Global Health
Professor of Medicine, UNSW Sydney Cardiologist, Royal Prince Alfred Hospital

“Looking forward to continuing to work with you all.”